OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2021
(7)
2025
(3)
2022
(3)
2023
(2)
2020
(2)
2024
(1)
2019
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
MicroRNA regulation postbleomycin due to the R213G extracellular superoxide dismutase variant is predicted to suppress inflammatory and immune pathways.
Not available
S-EPMC7311677
|
biostudies-literature
Cite
Nested polymerase chain reaction and sequence- based detection of leishmania infection of sand flies in recently emerged endemic focus of zoonotic cutaneous leishmaniasis, southern iran.
Not available
S-EPMC3771217
|
biostudies-literature
Cite
Mantle-flow diversion beneath the Iranian plateau induced by Zagros' lithospheric keel.
Not available
S-EPMC7854601
|
biostudies-literature
Cite
Common Variations in Prothrombotic Genes and Susceptibility to Ischemic Stroke in Young Patients: A Case-Control Study in Southeast Iran.
Not available
S-EPMC6409550
|
biostudies-literature
Cite
Biallelic variants in TMEM222 cause a new autosomal recessive neurodevelopmental disorder.
Not available
S-EPMC8725574
|
biostudies-literature
Cite
The Biology of Vasopressin.
Not available
S-EPMC7832310
|
biostudies-literature
Cite
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer: An International, Paired, Noninferiority, Confirmatory Observer Study.
Not available
S-EPMC11769734
|
biostudies-literature
Cite
Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021.
Not available
S-EPMC11876102
|
biostudies-literature
Cite
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
Not available
S-EPMC11121021
|
biostudies-literature
Cite
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets